In Nature this week: method to limit genetic side effects of gene therapy in an animal model, and more.
A new analysis in JAMA says the US is losing its historical lead in biomedical research investment and output.
The University of California Press' new open-access journal Collabra plans to pay its reviewers, ScienceInsider says.
A DNA-barcoding approach can help trace air and food contaminants, developers say.
In Cell this week: small RNAs of quorum sensing, alternative splicing in neurons, and more.
Houseflies seem to have co-evolved with people, and have good and bad roles to play, New Scientist says.
A majority of US adults say they'd share their health data for research, but that percentage is down from a previous poll, NPR reports.
Observers wonder whether Roche's investment into Foundation Medicine will be a replay of its Genentech acquisition.
In PNAS this week: mutations linked to colorectal cancer in African-Americans, draft Tibetan hulless barley genome, and more.
Despite a push toward open-access, Vox's Julia Belluz writes that traditional academic publishers are entrenched.
Baylor researchers develop a 3D map of how the genome folds.
A new report from FASEB not only calls for increases in biomedical funding, but also new approaches.
In PLOS this week: QTLs linked to blood metabolite levels, methylation patterns in Arabidopsis thaliana, and more.
Researchers at every stage of their careers are dealing with funding woes, Steve Caplan says at the Guardian.
A new initiative aims to characterize the diversity of seed banks.
A researcher looks into how much sway outside peer reviewers' scores have on funding decisions at MRC.
In Science this week: new factor in DNA double-strand break repair process, and more.
Researchers describe in Nature a new approach for scouring soil microbes for antibiotics.
Big data may house the answers to certain clinical or other questions, but NPR asks whether is it ready for wide use.
Mary Lyon, the discoverer of X-inactivation, has died.
Novartis looks toward employing the CRISPR genome-editing tool to develop new therapeutics and as a research tool.
In Nature this week: genes and evolutionary forces behind colorectal cancer, new site-directed mutagenesis approach, and more.
Cheaper testing is enabling more widespread carrier screening of prospective parents.
The announcement yesterday that Genentech is partnering with consumer genomics firm 23andMe has raised a couple of eyebrows across the Internet.
The National Center for Advancing Translational Sciences has licensed rights to a drug to treat Niemann-Pick Type C disease, the Wall Street Journal reports.